Archive

Gout increases diabetes risk, especially among women

Written by Bruce Sylvester | 13 Oct 2014

by Bruce Sylvester: Gout is associated with an increased risk of developing type 2 diabetes, researchers reported on Oct 2, 2014 in the British Medical Journal/BMJ. And the… read more.

Metformin treatment associated with low thyroid hormone

Written by Bruce Sylvester | 1 Oct 2014

by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.

Higher BMI associated with 10 common cancers

Written by Lorraine Carolan | 24 Sep 2014

by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.

WTC Report 2014: Should we set limits on an acceptable BMI for transplantation?

Written by Lorraine Carolan | 12 Sep 2014

By William Bernal, King’s College Hospital, London, UK. Body mass index (BMI; weight in kilograms divided by height in metres squared) is an important measurement for assessing perioperative… read more.

WTC Report 2014: Are the early quality of life benefits sustained long-term after liver transplantation? A 10-year longitudinal diagnosis stratified evaluation

Written by Lorraine Carolan | 8 Sep 2014

By Vincent H Karam et al, Hôpital Paul Brousse, Villejuif, France. Liver transplantation is associated with consistent improvements in quality of life in the first three years after… read more.

FDA Highlights: Fenofibrate reduces cardiovascular events in type-2 diabetes, especially for women

Written by Bruce Sylvester | 29 Aug 2014

by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.

ILTS 2014: Liver-directed cellular therapy – hope or hype?

Written by Lorraine Carolan | 7 Aug 2014

Feature Symposium. Stephen Strom, Karolinska Institutet, Stockholm, Sweden. Luc van der Laan, Erasmus Medical Center, Rotterdam, the Netherlands. Alberto Sanchez-Fueyo, King’s College Hospital, London, UK. David Hay, University… read more.

Joint International Congress of ILTS, ELITA and LICAGE 2014: Making the most of a new liver

Written by Lorraine Carolan | 4 Aug 2014

by Professor John O’Grady, Kings College Hospital, London – Liver transplantation is highly successful from the technical perspective, returning the majority of patients to a level of health… read more.

High-salt diet increases threat of ensuing cardiovascular disease in type 2 diabetes

Written by Bruce Sylvester | 30 Jul 2014

by Bruce Sylvester – Type 2 diabetes patients consuming a high-salt diet double their risk of developing cardiovascular disease, researchers reported on July 22, 2014 in the Journal… read more.

Press Release: OZURDEX® Receives European positive opinion for the treatment of the sight threatening condition, Diabetic Macular Oedema (DME)

Written by Lorraine Carolan | 29 Jul 2014

Sustained release treatment option could soon be available for diabetic patients in 28 countries of the European Union.

EMA Highlights: Green light for new medicines

Written by Gary Finnegan | 16 Jul 2014

by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.

ADA 2014 Report: More evidence for Canola Oil

Written by Lorraine Carolan | 7 Jul 2014

Adding canola oil to the diet improved glycemic control and reduced cardiovascular risk in type 2 diabetes in one study, while an overall healthier diet reduced risk of… read more.

« Previous 1 … 20 21 22 23 24 … 35 Next »

Archive

Subscribe for our mailing list

Follow Us